Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women.

Slides:



Advertisements
Similar presentations
Repositioning Prevention and Control of Cancers of Reproductive Organs in Kenya Repositioning Prevention and Control of Cancers of Reproductive Organs.
Advertisements

Cervical Screening and HPV testing
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer American Cancer Society Georgia Department of Human Resources The University of Georgia Cooperative Extension Service.
IL BCCP Questions.
Updates on Pap Smear Guidelines 2014
Treatment Options for CIN Cervical Cancer screening is designed to detect CIN If CIN is present treatment should theoretically avoid subsequent cancer.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Prevalence of anal Human Papillomavirus (HPV) infection and anal squamous intraepithelial.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
Screening for Cervical Cancer
Benign and premalignant disease of the cervix
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
Case Presentations: Pre-Invasive Cervical Neoplasia
Cervical Cancer Screening
Bayesian Modelling for Clinical Decision Support: Cervical Cancer Screening1/31 University of Pittsburgh Medical Center (UPMC) Magee-Womens Hospital (MWH)
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Screening for Cervical Cancer Max Brinsmead MB BS PhD May 2015.
SoftPAP® A Novel Collection Device for Cervical Cytology.
Current guidelines for Cervical Cancer Screening
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
Premalignant lesions of the cervix. Applied anatomy.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
HIV Infection Increases Risk of ASCUS and Subsequent Development of SILs Slideset on: Duerr A, Paramsothy P, Jamieson DJ, et al. Effect of HIV infection.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
Cervical Cancer Screening NURS 541: Women’s Healthcare – Diagnosis and Management.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Anal Cancer: The Bottom Line
Contact: PRELIMINARY RESULTS OF FIRST HPV PRIMARY SCREENING PRIVATE SECTOR IN BUENOS AIRES FEMALE POPULATION R. Jiménez del Toro,
Cervical Cancer Screening
Public Health England leads the NHS Screening Programmes
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
Trreatment of Preinvasive Lesions
Colposcopic Biopsy Results of HPV 16 and 18 patients in Bartın
Earlier treatment and lower mortality in infants Initiating ART at
INTRODUCTION: CERVICAL CANCER SCREENING
No conflicts of interest
Cervical Cancer in California
Cervical Cancer Colposcopy & Treatment
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Efficacy of random cervical biopsy and routine endocervical curettage in subjects with normal colposcopy.
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Obstetrician and Gynecologist Malawi Inaugural Cancer Symposium
NHS Cervical Screening Programme, England : Graphs
F.Behnamfar Gynecology Oncology Fellow Professor
Updates on Pap Smear Guidelines 2014
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
Ina U. Park MD, MS James Ogilvie, MD Lindsay Darrah, MD
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia  A. Gradíssimo Oliveira, C. Delgado,
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Management of the Abnormal Pap Smear.
Assessment of the utilization of prevention of mother-to-child transmission of HIV services and health outcomes of infants born to HIV positive mothers.
SBÜ KAYSERİ ERH Doç. Dr. Gökhan Açmaz
Public Health England leads the NHS Screening Programmes
Management and Development for Health (MDH)
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Cervical Screening for Dysplasia and Cancer in Patients with HIV
Primary HPV test screening
Neoplasia of the cervix
Cervical excisional treatment of young women: A population-based study
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
SH-sheikhhasani Gyn-oncologist
Downgrading -IN 2, Diagnoses and Predicting Higher-grade Lesions
AIDS 2018 | Abstract No. TUPDC0102 | Tuesday July 24, 2018
Fig. 1. Flowchart of inclusion and exclusion criteria of the study population.ASC-US, atypical squamous cells of undetermined significance; CIN, cervical.
Cumulative probability of CIN2 stratified by HPV test results.
Presentation transcript:

Risk factors for cervical intraepithelial neoplasia recurrence after loop electrosurgical excision procedure in HIV-1-infected and non-infected women Maria Inês Miranda LIMA (1) Victor Hugo MELO (2) Celso Pedro TAFURI (1) Luiza Miranda LIMA (3) Angela Cristina Labanca ARAÚJO (1) Mark Drew Crosland GUIMARÃES (1) (1) School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil (2) Belo Horizonte City Health Department (3) Medical Science School of Medicine

Background CERVICAL CANCER: High incidence of Cervical Cancer in Brazil (22/100,000 women in 2005) Cervical Intraepithelial Neoplasia (CIN) is a precursor of cervical cancer and is highly associated with HPV infection Early Dx of CIN can prevent new cases of CC (Cytology, Colposcopy, Biopsy) LEEP (Electrosurgical Excision Procedure) has been extensively used in Brazil

Background AIDS epidemic in Brazil (up to 2005: 370,000 cases) Women Heterosexual transmission Lower income and education HIV – Cervical cancer: Higher incidence of CIN and CC among HIV positive women Evidence of higher incidence of recurrence of CIN among HIV positive women There is no published data in Brazil regarding recurrence of CIN comparing HIV positive and negative women

Objective To assess factors associated with recurrence of cervical intraepithelial neoplasia after conization by LEEP in HIV infected and non-infected women

Methods Colposcopy Biopsy DYNAMIC COHORT STUDY Population: Public Cervical Pathology Referral Service, Belo Horizonte, Brazil Referred from other public primary care units or HIV services Screening criteria: Abnormal cytology (Bethesda,1999) OR Normal cytology with Positive Schiller test Colposcopy Biopsy

Methods Elegibility criteria for LEEP: Age > 18 years old Informed consent Dx of Cervical Intraepithelial Neoplasia (CIN): HSIL lesions or persistent LSIL lesions for HIV negative women HSIL or LSIL for HIV positive women Exclusions: Pregnant women Other Dx: Cervicitis, Invasive Cancer, Micro-invasive Cancer

Methods Recurrence of CIN: First recurrence Cytology and Colposcopy If abnormal or normal with positive Schiller test Biopsy: HSIL lesions or persistent LSIL lesions

Methods Statistical analysis: Cox Proportional Hazard Model (Univariate and Multivariate) Kaplan-Meier Survival Curves Variables of interest: HIV status, Histology, Glandular involvement, Margins, Number of sex partners, Age, Smoking Hx, HPV, Viral Load and CD4+ Cell count.

Results n ( % ) or Mean SCREENED AND BIOPSIED 206 (100) EXCLUDED 5 ( 2) PARTICIPANTS 201 ( 98) BIOPSIED DURING FOLLOW-UP 73 ( 36) Cumulative incidence 40 ( 20) Incidence / 1,000 women-months 10.2 Mean number of visits 4.6 Mean Time of follow-up (Median) 19.4 (18.6)

Results Variable n (%) Age (> 35y.o.) 126 (63) Number of lifetime partners (< 6) 142 (71) Smoking Hx 68 (34) HIV Positive 94 (47) Cytology (HSIL) 62 (31) Biopsy (HSIL) 114 (57) Histopathology (HSIL) 129 (64) Positive margins 45 (24) Glandular involvement 21 (10)

Results: Multivariate Analysis Variable RH (95% CI) p-Value HIV Status (Pos) 3.00 (1.38 – 6.48) 0.005 Glandular involvement 3.46 (1.71 – 7.01) 0.000 Positive Margin 2.04 (1.05 – 3.98) 0.035 RH=Relative Hazard

Positive margins and glandular involvement Normal Duct Positive margin Positive margin Glandular involvement

Conclusions The incidence of CIN recurrence in this population is high. HIV infection, positive margins and glandular involvement are independent co-factors. More careful follow-up of these women is necessary, specially among HIV positive ones. Histopathology indicates HPV infection in over 95%. However, PCR is recommended for sub-typing and is currently under way. Adherence to ARVT and Viral load will be further explored among HIV positive women.